An interventional study of wireless monitoring in Inpatient Facililty Diagnoses, sponsored by King Abdullah International Medical Research Center. Recruiting at 1 site in Saudi Arabia. Open to participants aged 14 Years and older. Per ClinicalTrials.gov, last updated 2026-02-27.
Sponsored by King Abdullah International Medical Research Center · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The study evaluates whether implementing a wireless monitoring system for patients admitted to hospital wards reduces mortality and cardiopulmonary failure.
The trial is designed as a stepped-wedge cluster RCT. Hospital wards (which constitute clusters in this design) will be randomized to have wireless monitoring, 7 wards at a time, with each 7 wards constituting a sequence. The study consists of 5 periods of two-month sequences followed by a one-month transition time with a phased introduction of the intervention. In the first period, all wards will have no wireless monitoring. After a baseline period of 2 (+1 washout) months, the intervention (monitoring system) will be implemented in a randomly selected new sequence every 3-month period until the intervention is implemented in all sequences.
King Abdullah International Medical Research Center is the lead sponsor of 46 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Ward level Inpatient wards, defined as wards used to manage adult inpatients.
Patient level
Exclusion Criteria:
Ward level
Patient level No commitment for full life support at the time of arrival to the study ward (designated as Do-Not-Resuscitate status)
Wireless monitoring will be applied on patients who are at high risk, identified as having a National Early Warning Score (NEWS)-2 score of 5 or higher, patients with lower NEWS-2 scores if the clinical team has a clinical concern, patients with Critical Care Response Team (CCRT) activation regardless of NEWS-2 score and post-ICU discharges regardless of NEWS-2 score. The technology allows to have alarms for patients who meet preset thresholds for vital signs. These alarms are transmitted through a mobile device to the charge nurse of the related ward. The wireless system will be monitored 24/7 by a critical care nurse
Usual care with no wireless monitoring.
The monitoring wireless system will continuously monitor the heart rate, oxygen saturation (SpO2), respiratory rate, and blood pressure and in selected patients electrocardiography (ECG).
Composite endpoint of 30-day in-hospital mortality, cardiac arrest, requirement of vasopressor or intubation
After hospital admission within 30 days
Time frame: 30 days
Cardiac arrest
cardiac arrest within 30 days of hospital admission
Time frame: 30 days
Requirement of vasopressors
use of vasopressors/inotropic support
Time frame: within 30 days of hospital admission
Requirement of intubation
need for mechanical ventilation within 30 days of hospital admission
Time frame: 30 days
Hospital length of stay
censored at 90 days
Time frame: 90 days
Transfer to ICU
ICU admission within 30 days of hospital admission
Time frame: 30 days
ICU- free days
in the first 30 days of hospital admission
Time frame: 30 days
CCRT activation
Critical care response team activation within 30 days of hospital admission
Time frame: 30 days
Plan to share: Yes — Data will be shared at the discretion of the Principal investigator
Started Feb 2026 (actual). Primary completion is estimated for Dec 2026, 10 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
King Abdullah International Medical Research Center